Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Clinical trial NCT04445519 · COMPLETED
Trial details
- NCT number
- NCT04445519
- Sponsor
- Nicox Ophthalmics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2022-09-16
- Enrollment
- 691
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.